Cerebrolysin in moderate to moderately severe Alzheimer's disease: a subgroup analysis of efficacy and safety

被引：0
|
作者：
Alvarez, A.
Sampedro, C.
Couceiro, V.
Cacabelos, R.
Aleixandre, M. [1 ,2 ]
Doppler, E. [3 ]
Moessler, H. [3 ]
机构：
[1] Univ Granada, Fac Psychol, Granada, Spain
[2] A Coruna, EuroEspes Biomed Res Ctr, Dept Neuropharmacol, Granada, Spain
[3] Ebewe Pharma, Unterach, Austria
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2008年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：24 / 24
页数：1
相关论文
共 50 条
  • [1] Cerebrolysin - Efficacy and safety in moderate to moderately severe Alzheimer's disease: Subgroup analysis of a randomized, double-blind, placebo-controlled trial
    Moessler, H
    Alvarez, AX
    Cacabelos, R
    NEUROBIOLOGY OF AGING, 2004, 25 : S207 - S207
  • [2] Efficacy and safety of Cerebrolysin in moderate to moderately severe Alzheimer's disease: results of a randomized, double-blind, controlled trial investigating three dosages of Cerebrolysin
    Alvarez, X. A.
    Cacabelos, R.
    Sampedro, C.
    Aleixandre, M.
    Linares, C.
    Granizo, E.
    Doppler, E.
    Moessler, H.
    EUROPEAN JOURNAL OF NEUROLOGY, 2011, 18 (01) : 59 - 68
  • [3] Efficacy of rivastigmine over 4 years in mild, moderate and moderately severe Alzheimer's disease
    Kaufer, D
    Quarg, P
    Spiegel, R
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S210 - S210
  • [4] Efficacy of rivastigmine in subjects with moderately severe Alzheimer's disease
    Burns, A
    Spiegel, R
    Quarg, P
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2004, 19 (03) : 243 - 249
  • [5] Consistent long-term efficacy of rivastigmine in mild, moderate and moderately severe Alzheimer's disease
    Kaufer, D
    Quarg, P
    Spiegel, R
    NEUROBIOLOGY OF AGING, 2004, 25 : S101 - S101
  • [6] Consistent long-term efficacy of rivastigmine in mild, moderate and moderately severe Alzheimer's disease
    Kaufer, D.
    Quarg, P.
    Spiegel, R.
    EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 : 186 - 186
  • [7] Efficacy of memantine in moderate to severe Alzheimer's disease
    Wilkinson, D.
    EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 : 318 - 318
  • [8] The efficacy and safety of ENA-713 in patients with mild to moderately severe Alzheimer's disease
    Corey-Bloom, J
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1998, 46 (09) : S12 - S12
  • [9] Neuropsychological profile of Alzheimer's, disease in women: Moderate and moderately severe cognitive decline
    Garre-Olmo J.
    López-Pousa S.
    Vilalta-Franch J.
    Turon-Estrada A.
    Lozano-Gallego M.
    Hernández-Ferràndiz M.
    Gelada-Batlle E.
    Cruz-Reina M.M.
    Morante-Muñoz V.
    Peralta-Rodríguez J.
    Archives of Women’s Mental Health, 2004, 7 (1) : 27 - 36
  • [10] Efficacy and safety of memantine in moderate-to-severe Alzheimer disease: The evidence to date
    Bullock, R
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2006, 20 (01): : 23 - 29
12345